Cost and Utilization Patterns of Fentanyl Transdermal System and Oxycodone Hydrochloride Controlled- Release in a California Medicaid Population
نویسندگان
چکیده
JESSE D. MALKIN, M.Phil., Ph.D., worked on this paper while at Covance Health Economics and Outcomes Services Inc., Gaithersburg, Maryland. He is currently with the RAND Corporation, Arlington, Virginia; STACEY J. ACKERMAN, MSE, Ph.D., is with Covance Health Economics and Outcomes Services Inc.; JEFF SCHEIN, Dr.Ph, M.Ph., and JULIE LOCKLEAR, Pharm.D., are with Janssen Pharmaceutica, Titusville, New Jersey. MICHAEL ASHBURN, M.D., is with the Department of Anesthesia, University of Utah Health Science Center, Salt Lake City, Utah.
منابع مشابه
Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain.
BACKGROUND Although use of long-acting opioid analgesics has increased for chronic nonmalignant pain management, little is known about patient-reported utilization patterns. OBJECTIVE To assess patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride (HCl) controlled-release among patients with chronic nonmalignant pain and to compare these patterns to ...
متن کاملEconomic evaluation of the fentanyl transdermal system for the treatment of chronic moderate to severe pain.
The fentanyl transdermal system (Duragesic) is an opioid analgesic indicated for the management of chronic moderate to severe pain. The purpose of this analysis is to estimate its economic value compared to two long-acting oral opioids. A cost-utility analysis was performed using a three-phased decision analytic model. The transdermal system had the highest expected cost during the first year o...
متن کاملTherapy switching in patients receiving long-acting opioids.
BACKGROUND Patterns of therapy switching in patients receiving long-acting opioids have not been well documented. OBJECTIVE To compare therapy switching among patients beginning treatment with controlled-release (CR) oxycodone, transdermal fentanyl, or CR morphine sulfate. METHODS Using a US healthcare claims database, we identified patients beginning treatment with CR oxycodone, transderma...
متن کاملOpioid utilization patterns among medicare patients with diabetic peripheral neuropathy.
BACKGROUND Diabetic peripheral neuropathy (DPN) affects a large percentage of patients with type 2 diabetes and is associated with moderate-to-severe pain. Patients with DPN bear a substantial economic burden as a result of increased overall healthcare utilization. The reported costs of treating DPN are nearly $11 billion, with elderly (aged ≥65 years) patients with type 2 diabetes accounting f...
متن کاملSynergistic Effect of Chemical Enhancer And Iontophoresis For Transdermal Delivery Of Nebivolol Hydrochloride
The aim of the present study was to develop and investigate the feasibility of delivering Nebivolol as a transdermal patch by iontophoresis. The passive and electrically assisted transdermal delivery of Nebivolol hydrochloride by iontophoresis will improve the therapeutic efficacy and overcome the difficulties raised in oral drug delivery. Because of its extensive hepatic metabolism and low dos...
متن کامل